Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 989.85
-29.95 (-2.94%)
Sep 10, 2025, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 378.68 billion as of September 10, 2025. Its market cap has increased by 40.57% in one year.
Market Cap
378.68B
Enterprise Value
380.11B
Revenue
12.59B
Ranking
n/a
PE Ratio
105.35
Stock Price
989.85
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 378.68B, an increase of 1,123,424.95%. That is a compound annual growth rate of 443.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 390.14B | 34.58% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.58B |
| Divi's Laboratories | 1,595.20B |
| Cipla | 1,254.77B |
| Apollo Hospitals Enterprise | 1,119.58B |
| Mankind Pharma | 1,052.78B |
| Zydus Lifesciences | 1,020.17B |
| Fortis Healthcare | 715.59B |
| Alkem Laboratories | 637.70B |